Diminished serum repetin levels in patients with schizophrenia and bipolar disorder - Wikidata - wikimedia - TriplyDB

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

http://www.wikidata.org/entity/Q35004034

about

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

http://www.wikidata.org/entity/Q35004034

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@ast

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@en

type

label

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@ast

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@en

prefLabel

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@ast

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@en

P1433

Q35004034-52C8DC4A-F31E-433F-ADAA-297655FBE7E5

P1476

Q35004034-A3547117-73B0-41C0-977B-56AD0672A105

P2093

Q35004034-1DBB0599-D0A0-4E65-B1F7-D186892E8C55

Q35004034-2F1139D5-5BB6-4C3C-BB62-57F8CC913966

Q35004034-37801AF6-A3B2-4E14-B5C9-64AE032C55E0

Q35004034-3E55A65A-C4FF-437D-BA41-D0C58FE5EC2F

Q35004034-3E7CBA40-890A-4626-86D8-D6E70A6E0CB1

Q35004034-41D90C24-8F9D-46AA-9A3C-A07EACED50C9

Q35004034-4508FDF6-4584-4849-B91E-64B6B7376352

Q35004034-45337FD7-64C5-480E-95A5-E0A154011789

Q35004034-5E8944FB-9043-4CC7-BA03-8D3E228B0F6C

Q35004034-618FD016-0C44-42CB-8E16-441FFC106F9A

P2860

Q35004034-0E1EC48E-68AB-4126-85EA-ED0295C73ECF

Q35004034-0F1386B4-4C1C-4A8A-A111-7EED8D4208A0

Q35004034-107CFC96-DA98-467C-9B1A-E53406BF3BEE

Q35004034-11536268-6A03-42F7-8351-DFCFCEF6E5DD

Q35004034-13A3B570-F760-4DF1-82F1-91EFBD619559

Q35004034-18C6C84E-A2C1-4728-9A81-27DE8192A846

Q35004034-19866EA4-1B12-4BCF-B20F-8E55FA610A21

Q35004034-37FC2675-EBC3-4EB7-A271-388A9C1A918B

Q35004034-3DC9DF6A-8411-4D85-BCDC-F42B58AF579E

Q35004034-3E72D4BF-A8C2-4F66-86C8-D7E3AD35766A

P2888

Q35004034-5AA1803D-60F8-4458-8ACF-9B76D0AB461D

P304

Q35004034-D2FB3380-2612-43F1-A62C-5AA70F70417F

P31

Q35004034-0E52A735-4482-47FA-8A70-722B11ADC8BC

P356

Q35004034-99CBCDE5-128C-46E7-BDEB-D321DF2FA0F5

P407

Q35004034-469F22A7-BAD5-4358-B4F6-58F3D5FC0D71

P478

Q35004034-07F8A9D6-7509-4802-B8EE-558AB071A50E

P50

Q35004034-955BA850-6A1F-40D2-A785-961510628480

P577

Q35004034-2F6B3734-A69A-4292-A45E-631F330308F3

P5875

Q35004034-E1F37552-A722-49E0-853B-A4C745083069

P698

Q35004034-0BD87A6E-F456-4593-A0C3-A77712A519FD

P921

Q35004034-ABB04379-33D4-4302-BA7F-EFAF67710403

Q35004034-F10A9688-DB78-4F7A-A87A-1E0C8A5BD3DD

P932

Q35004034-422BB420-CF3B-45C8-8CDC-CA3BBB5400AF

P356

P1433

Scientific Reports

P1476

Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

@en

P2093

Bomiao Ju

http://www.w3.org/2001/XMLSchema#string

Chang Xu

http://www.w3.org/2001/XMLSchema#string

Chanyuan Wang

http://www.w3.org/2001/XMLSchema#string

Chengyuan Yu

http://www.w3.org/2001/XMLSchema#string

Ethan Will Taylor

http://www.w3.org/2001/XMLSchema#string

Hui Qiao

http://www.w3.org/2001/XMLSchema#string

Huixun Ren

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Shaoli Cheng

http://www.w3.org/2001/XMLSchema#string

Shuai Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Hippocampal atrophy in recurrent major depression

Klf4 is a transcription factor required for establishing the barrier function of the skin

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation

Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein

Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system

Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.

Hippocampal interneurons are abnormal in schizophrenia.

Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

P2888

P304

7977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP07977

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271330242

http://www.w3.org/2001/XMLSchema#string

P698

25613293

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

4303898

http://www.w3.org/2001/XMLSchema#string